$CYN
Cyngn Inc.

2024 Q4 Form 10-Q Financial Statement

#000121390024095459 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $47.58K
YoY Change 88.75%
Cost Of Revenue $157.3K
YoY Change 270.75%
Gross Profit -$109.7K
YoY Change 537.45%
Gross Profit Margin -230.47%
Selling, General & Admin $2.603M
YoY Change -2.26%
% of Gross Profit
Research & Development $2.796M
YoY Change -4.56%
% of Gross Profit
Depreciation & Amortization $54.76K
YoY Change -38.9%
% of Gross Profit
Operating Expenses $2.796M
YoY Change -4.56%
Operating Profit -$5.508M
YoY Change -1.81%
Interest Expense $46.34K
YoY Change 40.8%
% of Operating Profit
Other Income/Expense, Net $80.80K
YoY Change -41.53%
Pretax Income -$5.427M
YoY Change -0.81%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.427M
YoY Change -0.81%
Net Earnings / Revenue -11405.93%
Basic Earnings Per Share -$2.74
Diluted Earnings Per Share -$2.74
COMMON SHARES
Basic Shares Outstanding 2.027M shares 2.027M shares
Diluted Shares Outstanding 1.982M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.787M
YoY Change -65.82%
Cash & Equivalents $1.974M
Short-Term Investments $812.8K
Other Short-Term Assets $1.288M
YoY Change 194.9%
Inventory $375.6K
Prepaid Expenses $118.6K
Receivables
Other Receivables $246.1K
Total Short-Term Assets $4.451M
YoY Change -48.2%
LONG-TERM ASSETS
Property, Plant & Equipment $2.067M
YoY Change 48.37%
Goodwill
YoY Change
Intangibles $1.488M
YoY Change 28.34%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.030M
YoY Change 36.24%
TOTAL ASSETS
Total Short-Term Assets $4.451M
Total Long-Term Assets $4.030M
Total Assets $8.481M
YoY Change -26.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.5K
YoY Change -18.72%
Accrued Expenses $457.3K
YoY Change 86.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.832M
YoY Change 35.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.832M
Total Long-Term Liabilities $0.00
Total Liabilities $1.832M
YoY Change 35.94%
SHAREHOLDERS EQUITY
Retained Earnings -$177.2M
YoY Change 15.67%
Common Stock $20.00
YoY Change -94.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.649M
YoY Change
Total Liabilities & Shareholders Equity $8.481M
YoY Change -26.57%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$5.427M
YoY Change -0.81%
Depreciation, Depletion And Amortization $54.76K
YoY Change -38.9%
Cash From Operating Activities -$5.325M
YoY Change 27.07%
INVESTING ACTIVITIES
Capital Expenditures $162.4K
YoY Change -61.72%
Acquisitions
YoY Change
Other Investing Activities -$241.5K
YoY Change -105.91%
Cash From Investing Activities -$403.9K
YoY Change -111.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.772M
YoY Change 75.26%
NET CHANGE
Cash From Operating Activities -5.325M
Cash From Investing Activities -403.9K
Cash From Financing Activities 1.772M
Net Change In Cash -3.957M
YoY Change -924.09%
FREE CASH FLOW
Cash From Operating Activities -$5.325M
Capital Expenditures $162.4K
Free Cash Flow -$5.487M
YoY Change 18.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170652800 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
cyngn Cash Paid During The Year For Income Taxes
CashPaidDuringTheYearForIncomeTaxes
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40932
dei Entity Registrant Name
EntityRegistrantName
CYNGN INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2007094
dei Entity Address Address Line1
EntityAddressAddressLine1
1015 O’Brien Dr
dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
924-5905
dei Security12b Title
Security12bTitle
Common stock, $0.00001
dei Trading Symbol
TradingSymbol
CYN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2026659 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1974441 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3591623 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
812750 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
4561928 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1664063 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1316426 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
4451254 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9469977 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2067411 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1486672 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
474149 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
992292 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1488328 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1084415 usd
CY2024Q3 us-gaap Assets
Assets
8481142 usd
CY2023Q4 us-gaap Assets
Assets
13033356 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
190488 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196963 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1136258 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1201142 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
505231 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
682718 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1831977 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2080823 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
317344 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1831977 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2398167 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2026575 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2026575 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
759831 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
759831 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
20 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
183883194 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177234049 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160017619 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6649165 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10635189 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8481142 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13033356 usd
CY2024Q3 us-gaap Revenues
Revenues
47584 usd
CY2023Q3 us-gaap Revenues
Revenues
25210 usd
us-gaap Revenues
Revenues
61762 usd
us-gaap Revenues
Revenues
1448961 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
157251 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
42414 usd
us-gaap Cost Of Revenue
CostOfRevenue
285949 usd
us-gaap Cost Of Revenue
CostOfRevenue
1121732 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2795583 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2929225 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9149357 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9697099 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2602952 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2663272 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7913222 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8580113 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
5555786 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
5634911 usd
us-gaap Costs And Expenses
CostsAndExpenses
17348528 usd
us-gaap Costs And Expenses
CostsAndExpenses
19398944 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5508202 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5609701 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17286766 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-17949983 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
46336 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
32905 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
45994 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
98698 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34467 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
105284 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24342 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
397616 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
80803 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
138189 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
70336 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
496314 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5427399 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5471512 usd
us-gaap Net Income Loss
NetIncomeLoss
-17216430 usd
us-gaap Net Income Loss
NetIncomeLoss
-17453669 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.74
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-35.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-35.5
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1981907 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1981907 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
496009 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
496009 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1333255 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1333255 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
491656 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
491656 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
13942044 usd
CY2023Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
21180 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1012511 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
460 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
719283 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5471512 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10202786 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9702835 usd
CY2024Q3 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
36169 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1772283 usd
CY2024Q3 cyngn Issuance Of Common Stocks Net Of Offering Costs
IssuanceOfCommonStocksNetOfOfferingCosts
-345 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
601791 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5427399 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6649165 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24117527 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
21180 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1012511 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
8527 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2517890 usd
us-gaap Net Income Loss
NetIncomeLoss
-17453669 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
10202786 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10635189 usd
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
138572 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
6789427 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-597 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
633493 usd
cyngn Issuance Of Common Stocks Net Of Offering Costs
IssuanceOfCommonStocksNetOfOfferingCosts
4569558 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
552 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1871466 usd
us-gaap Net Income Loss
NetIncomeLoss
-17216430 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6649165 usd
us-gaap Net Income Loss
NetIncomeLoss
-17216430 usd
us-gaap Net Income Loss
NetIncomeLoss
-17453669 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
692848 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
707337 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1871466 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2517890 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
105414 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
396141 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
118831 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
345122 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-261034 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6475 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
78414 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-559715 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-154967 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15550011 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14440102 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
739947 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
904417 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
540756 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
698527 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
130898 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
6755408 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
17050782 usd
cyngn Proceeds From Maturity Of Shortterm Investments
ProceedsFromMaturityOfShorttermInvestments
10610000 usd
cyngn Proceeds From Maturity Of Shortterm Investments
ProceedsFromMaturityOfShorttermInvestments
24892000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2573889 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6369172 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
6789427 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1012511 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4570110 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8527 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
597 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11358940 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1021038 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1617182 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7049892 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3591623 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10586273 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1974441 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3536381 usd
cyngn Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
RecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
2037052 usd
cyngn Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
RecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
464929 usd
cyngn Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses
AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
10997 usd
cyngn Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses
AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
20625 usd
us-gaap Net Income Loss
NetIncomeLoss
-17200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17500000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177200000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14400000 usd
CY2024Q3 us-gaap Cash
Cash
2000000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
800000 usd
CY2023Q4 us-gaap Cash
Cash
3600000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
4600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p>
CY2024Q3 us-gaap Cash
Cash
2000000 usd
CY2023Q4 us-gaap Cash
Cash
3600000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P15Y
CY2022Q2 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
100000 usd
CY2022Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
44346 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
63503 usd
us-gaap Advertising Expense
AdvertisingExpense
175345 usd
us-gaap Advertising Expense
AdvertisingExpense
102620 usd
CY2024Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
33069 usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7085 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
35150 usd
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
8336 usd
CY2024Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
196805 usd
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
0 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
375603 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
118572 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
385474 usd
CY2024Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
160149 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
155729 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
763624 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
765697 usd
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
246115 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
9526 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1664063 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1316426 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3059442 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2322009 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
992031 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
835337 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2067411 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1486672 usd
CY2024Q3 us-gaap Depreciation
Depreciation
54762 usd
CY2023Q3 us-gaap Depreciation
Depreciation
89625 usd
us-gaap Depreciation
Depreciation
151647 usd
us-gaap Depreciation
Depreciation
264127 usd
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
42500 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
41250 usd
CY2024Q3 cyngn Credit Card Payable Current
CreditCardPayableCurrent
135197 usd
CY2023Q4 cyngn Credit Card Payable Current
CreditCardPayableCurrent
1103 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
457275 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
214286 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
543786 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
985753 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1136258 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1201142 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
81000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
192316 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
320526 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
512842 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7611 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
505231 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M1D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M1D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0439 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0305 pure
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
159140 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
100251 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
519105 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
393162 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
174364 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
149051 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
518142 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
431250 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6185 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4751 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18012 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11960 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
118831 usd
CY2024Q3 us-gaap Salvage And Subrogation Recoveries Value
SalvageAndSubrogationRecoveriesValue
0 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
50000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6727 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
26909 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
26909 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
26909 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
26909 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1373965 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1488328 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2026575 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
759831 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
759831 shares
CY2024Q2 cyngn Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares
IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares
302000 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.00001
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.09999
cyngn Transaction Expenses Payable
TransactionExpensesPayable
5200000 usd
CY2023Q4 cyngn Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares
IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares
218666 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.00001
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.15
CY2023Q4 cyngn Transaction Expenses Payable
TransactionExpensesPayable
5000000 usd
CY2023Q4 cyngn Other Direct Costs
OtherDirectCosts
500000 usd
CY2023Q2 cyngn Commission Proceed Percentage
CommissionProceedPercentage
0.03 pure
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8597957 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
175468 usd
us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
60465 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-100
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5427399 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5471512 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1981907 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1981907 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
496009 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
496009 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.74
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.03
us-gaap Net Income Loss
NetIncomeLoss
-17216430 usd
us-gaap Net Income Loss
NetIncomeLoss
-17453669 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1333255 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1333255 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
491656 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
491656 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-35.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-35.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
CY2023Q4 cyngn Common Stock Outstanding Percentage
CommonStockOutstandingPercentage
0.15 pure
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
86438000000 shares
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6565 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
167430 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
100.13
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M29D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3550 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.73
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2950 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
142.36
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
168030 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
97.38
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
168030 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
97.38
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
104994 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
96.23
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y6M21D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
175063 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
104.27
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M13D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42530 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6716 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13749 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
142.89
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
168030 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
97.38
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
168030 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
97.38
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y7M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
104994 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
96.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y6M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.99
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
55.13
CY2024Q3 us-gaap Share Price
SharePrice
10.92
CY2023Q3 us-gaap Share Price
SharePrice
102.4
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0394 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0363 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.536 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5274 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
601791 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
719283 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1871466 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2517890 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4200000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
cyngn Cash Paid During The Year For Income Taxes
CashPaidDuringTheYearForIncomeTaxes
usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
usd
CY2023Q4 us-gaap Salvage And Subrogation Recoveries Value
SalvageAndSubrogationRecoveriesValue
usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001874097

Files In Submission

Name View Source Status
0001213900-24-095459-index-headers.html Edgar Link pending
0001213900-24-095459-index.html Edgar Link pending
0001213900-24-095459.txt Edgar Link pending
0001213900-24-095459-xbrl.zip Edgar Link pending
cyngn-20240930.xsd Edgar Link pending
cyngn-20240930_cal.xml Edgar Link unprocessable
ea0217979-10q_cyngn.htm Edgar Link pending
ea021797901ex31-1_cyngn.htm Edgar Link pending
ea021797901ex31-2_cyngn.htm Edgar Link pending
ea021797901ex32-1_cyngn.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cyngn-20240930_lab.xml Edgar Link unprocessable
cyngn-20240930_pre.xml Edgar Link unprocessable
ea0217979-10q_cyngn_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cyngn-20240930_def.xml Edgar Link unprocessable